Pharma & Biotech

Eli Lilly, currently a dominant force in the pharmaceutical sector largely due to the success of its weight-loss medications, is...

Biotechnology firm Ocugen finds itself at a critical juncture. With its shares under significant pressure, CEO Dr. Shankar Musunuri is...

The Danish pharmaceutical leader is implementing a dramatic strategic pivot that could fundamentally alter competitive dynamics in the multibillion-dollar weight-loss...

The Danish pharmaceutical giant Novo Nordisk is navigating its most significant corporate overhaul in years. While headlines focus on workforce...

Today marks a pivotal moment for InnoCan Pharma as investors await financial results that could determine the stock's near-term trajectory....

After a punishing year that saw its value cut in half, Redcare Pharmacy shares are attracting renewed attention following a...

BioNxt Solutions has achieved a significant milestone in its commercial strategy. The biotechnology firm has been granted exclusive rights to...

The biotechnology firm aTyr Pharma is confronting a severe crisis after its pivotal Phase 3 clinical trial ended in failure....

The formal dissolution of one of biotech's most prominent partnerships has rattled investors, with Pfizer's complete exit from its BioNTech...

PDS Biotechnology Corporation's stock is experiencing significant downward momentum amid intense volatility, even as the company reports encouraging clinical trial...